Smartkarma Daily Briefs

• On June 24, Crowdstrike Holdings (CRWD US) will officially join the S&P 500, which follows strong financial results and guidance. Investors anticipated this inclusion, driven by improved profitability and operational efficiency.
• The volume traded has so far been on average 2x the 3-month daily average prior to the news. The enduring effect will be on liquidity (hedging basket for index exposure).
• CrowdStrike’s inclusion in the S&P 500 index increases the representation of pure cybersecurity stocks. Median IBES consensus PT is $400 (7.5% upside).

• The gap between OPEC and IEA’s oil demand forecasts widened: OPEC kept its 2024 forecast at 2.25m bpd, while IEA lowered its forecast to 960k bpd from 1.1m bpd.
• Europe’s attempt to cut Russian LNG imports grows stronger, as the French Senate Committee recommends cutting Russian dependence.
• Since 17/June, Energy majors began recovering. Berkshire increased its holdings in Occidental, while Shell expanded its LNG market access by acquiring Pavilion Energy.

• Back in 2016, IMS Health and Quintiles went through a merger of equals to form “QuintilesIMS” which was later renamed to be “IQVIA” in 2017.
• “I” and “Q” stand for IMS Health and Quintiles respectively and “VIA” means “by way of”.
• Since IMS and Quintiles both used to be separate public companies, let me discuss these two businesses separately at first before getting into the details of their post-merger status.

• Today’s edition of Crypto Moves builds on this week’s Crypto Crisp, where we advocated a bullish outlook on the crypto market.
• I have examined all of our charts to find every reason to maintain a long position in the current crypto market. Let us dive in.
• From this week onwards, we anticipate a significant increase in liquidity over the next few months. This liquidity forecast model has been highly accurate in recent months.

Key points

• United Parks & Resorts (PRKS) is proposing a $500 million share repurchase authorization to decrease share count and float significantly at current prices.
• The buyback, if approved, could be completed by the end of 2024 and potentially drive double-digit EBITDA growth, leading to an 80% increase in stock price to $100.
• With a leverage of 2.5x EBITDA, the company may also be a candidate for sale or privatization, with Hill Path ownership increasing to 49% and potential for significant premium buyouts.

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

• SPRB is developing tildacerfont, a second-generation CRF1 antagonist for CAH treatment
• Recent Phase 2 trial failure doesn’t negate potential, but upcoming trial results are more relevant
• Market overreaction to negative news creates attractive opportunity for investors, with upside potential and downside protection for SPRB

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.